Cowen And Company, LLC Ocular Therapeutix, Inc Transaction History
Cowen And Company, LLC
- $3.91 Billion
- Q2 2024
A detailed history of Cowen And Company, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Cowen And Company, LLC holds 32,900 shares of OCUL stock, worth $286,230. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,900Holding current value
$286,230% of portfolio
0.0%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding OCUL
# of Institutions
151Shares Held
136MCall Options Held
86.4KPut Options Held
263K-
Summer Road LLC West Palm Beach, FL14.9MShares$130 Million98.56% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$111 Million9.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$111 Million2.86% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$100 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.61MShares$74.9 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $670M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...